EMulate Therapeutics is a clinical-stage therapeutic device company. It offers EMulate Therapeutics Voyager, a non-invasive device that utilizes radiofrequency energy to regulate signaling and metabolic pathways on the molecular and genetic levels. The company focuses on the treatment of patients with brain cancer.